Overview

OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Pilot Trial of CA4P with Avastin in Recurrent Gliomas
Phase:
Phase 1
Details
Lead Sponsor:
West Virginia University
Treatments:
Bevacizumab
Fosbretabulin